FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 141 filers reported holding FIVE PRIME THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 5.21 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $5,953,000 | +175.0% | 158,042 | +24.1% | 0.00% | +300.0% |
| Q4 2020 | $2,165,000 | +2001.9% | 127,327 | +483.7% | 0.00% | – |
| Q3 2020 | $103,000 | -36.0% | 21,814 | -17.6% | 0.00% | – |
| Q2 2020 | $161,000 | -48.2% | 26,468 | -48.6% | 0.00% | -100.0% |
| Q2 2019 | $311,000 | +182.7% | 51,544 | +334.2% | 0.00% | – |
| Q4 2018 | $110,000 | -45.3% | 11,870 | +77.8% | 0.00% | -100.0% |
| Q2 2017 | $201,000 | -63.3% | 6,677 | -50.5% | 0.00% | -66.7% |
| Q1 2016 | $548,000 | +84.5% | 13,488 | +13.0% | 0.00% | +50.0% |
| Q2 2015 | $297,000 | – | 11,939 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|